Literature DB >> 1902161

Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator.

S Greenberg1, R Kosinski, J Daniels.   

Abstract

Thrombotic occlusion of the superior vena cava is an uncommon but serious complication of chronic indwelling venous catheters. Several reports have shown thrombolytic therapy with intravenous streptokinase or urokinase to be effective in the treatment of this condition. We report a case of superior vena cava thrombosis in a 53-year-old woman receiving chemotherapy for breast carcinoma through a subcutaneously implanted venous access catheter who was successfully treated with peripheral infusion of recombinant tissue type plasminogen activator (rtPA).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902161     DOI: 10.1378/chest.99.5.1298

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator.

Authors:  S Rodenhuis; L G van't Hek; L T Vlasveld; R Kröger; R Dubbelman; R G van Tol
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

Review 2.  Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors:  A J Wagstaff; J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 3.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.